141 related articles for article (PubMed ID: 11830489)
21. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
[TBL] [Abstract][Full Text] [Related]
22. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML.
Kurata M; Rathe SK; Bailey NJ; Aumann NK; Jones JM; Veldhuijzen GW; Moriarity BS; Largaespada DA
Sci Rep; 2016 Nov; 6():36199. PubMed ID: 27808171
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
Beauséjour CM; Gagnon J; Primeau M; Momparler RL
Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
[TBL] [Abstract][Full Text] [Related]
25. Low expression of the deoxycytidine kinase (dCK) gene in a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra.
Kobayashi T; Kakihara T; Uchiyama M; Fukuda T; Kishi K; Shibata A
Leuk Lymphoma; 1994 Nov; 15(5-6):503-5. PubMed ID: 7874009
[TBL] [Abstract][Full Text] [Related]
26. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine.
Braess J; Wegendt C; Jahns-Streubel G; Kern W; Keye S; Unterhalt M; Schleyer E; Hiddemann W
Br J Haematol; 2000 May; 109(2):388-95. PubMed ID: 10848830
[TBL] [Abstract][Full Text] [Related]
27. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
28. Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells.
Braess J; Pförtner J; Kern W; Hiddemann W; Schleyer E
Ann Hematol; 1999 Nov; 78(11):514-20. PubMed ID: 10602895
[TBL] [Abstract][Full Text] [Related]
29. Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
Freiburghaus C; Emruli VK; Johansson A; Eskelund CW; Grønbæk K; Olsson R; Ek F; Jerkeman M; Ek S
BMC Cancer; 2018 Apr; 18(1):466. PubMed ID: 29695239
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase.
Kojima H; Iida M; Miyazaki H; Koga T; Moriyama H; Manome Y
Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):708-13. PubMed ID: 12049569
[TBL] [Abstract][Full Text] [Related]
31. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
[TBL] [Abstract][Full Text] [Related]
32. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
Kong XB; Tong WP; Chou TC
Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
[TBL] [Abstract][Full Text] [Related]
33. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.
Shi JY; Shi ZZ; Zhang SJ; Zhu YM; Gu BW; Li G; Bai XT; Gao XD; Hu J; Jin W; Huang W; Chen Z; Chen SJ
Pharmacogenetics; 2004 Nov; 14(11):759-68. PubMed ID: 15564883
[TBL] [Abstract][Full Text] [Related]
34. Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
Levin M; Stark M; Berman B; Assaraf YG
Cell Death Dis; 2019 May; 10(6):390. PubMed ID: 31101804
[TBL] [Abstract][Full Text] [Related]
35. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
36. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
[TBL] [Abstract][Full Text] [Related]
37. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs.
Beauséjour CM; Tremblay G; Momparler RL
Biochem Biophys Res Commun; 2000 Nov; 278(3):569-75. PubMed ID: 11095951
[TBL] [Abstract][Full Text] [Related]
38. No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
Visani G; Isidori A; Grafone T; Tosi P; Santini V; Malagola M; Martinelli G; Piccaluga PP; Gaziev D; Ottaviani E; Sparaventi G; Tura S
Leuk Lymphoma; 2004 Jul; 45(7):1361-4. PubMed ID: 15359633
[TBL] [Abstract][Full Text] [Related]
39. Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts.
Kawamura K; Namba H; Bahar R; Miyauchi M; Maeda T; Hamada H; Sakiyama S; Tagawa M
Cancer Lett; 2000 Aug; 156(2):151-7. PubMed ID: 10880764
[TBL] [Abstract][Full Text] [Related]
40. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
Reuter C; Schleyer E; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1997 Apr; 11(4):561-71. PubMed ID: 9096697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
